Great news for HCC Patients
Options
MyJourneywithCancer
Member Posts: 82
FDA approved the PD-1 inhibitor, nivolumab (Opdivo) for the treatment of hepatocellular carcinoma (HCC) after disease progression despite treatment with sorafenib.
More here:
http://cancerdiscovery.aacrjournals.org/content/early/2017/10/04/2159-8290.CD-NB2017-138.long
More here:
http://cancerdiscovery.aacrjournals.org/content/early/2017/10/04/2159-8290.CD-NB2017-138.long
0
Comments
-
Than you for info and never
Than you for info and never give up.
I beleive advanced technology could cure this HCC one day.
0 -
New life saving drugs
Hurray. We are so lucky to be alive in this time when liver disease and specifically liver cancer is making such huge strides.
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.2K Cancer specific
- 2.8K Anal Cancer
- 440 Bladder Cancer
- 306 Bone Cancers
- 1.6K Brain Cancer
- 28.4K Breast Cancer
- 391 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 12.9K Head and Neck Cancer
- 6.3K Kidney Cancer
- 666 Leukemia
- 789 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 235 Multiple Myeloma
- 7.1K Ovarian Cancer
- 53 Pancreatic Cancer
- 486 Peritoneal Cancer
- 5.3K Prostate Cancer
- 1.2K Rare and Other Cancers
- 532 Sarcoma
- 717 Skin Cancer
- 647 Stomach Cancer
- 190 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards